Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2011 Jun 16;117(24):6608-11.
doi: 10.1182/blood-2010-12-322834. Epub 2011 Apr 22.

Defective inhibition of B-cell proliferation by Wiskott-Aldrich syndrome protein-deficient regulatory T cells

Affiliations

Defective inhibition of B-cell proliferation by Wiskott-Aldrich syndrome protein-deficient regulatory T cells

Marsilio Adriani et al. Blood. .

Abstract

Wiskott-Aldrich syndrome (WAS) is an inherited immunodeficiency characterized by high incidence of autoantibody-mediated autoimmune complications. Such a feature has been associated with defective suppressor activity of WAS protein-deficient, naturally occurring CD4(+)CD25(+)Foxp3(+) regulatory T cells on responder T cells. However, it remains to be established whether the altered B-cell tolerance reported in WAS patients and Was knockout (WKO) mice is secondary to abnormalities in the direct suppression of B-cell function by nTreg cells or to impaired regulation of T-helper function. Because activated nTreg cells are known to induce granzyme B-mediated B-cell killing, we decided to evaluate the regulatory capabilities of WKO nTregs on B lymphocytes. We found that preactivated WKO nTreg cells failed to effectively suppress B-cell proliferation and that such a defect was associated with reduced killing of B cells and significantly decreased degranulation of granzyme B. Altogether, these results provide additional mechanistic insights into the loss of immune tolerance in WAS.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Preactivated WKO nTreg cells can suppress T-cell but not B-cell proliferation. nTreg, Tconv, and CD8+ T cells were isolated from WT and WKO mice and preactivated with anti-CD3 and IL-2. (A) Proliferation of freshly isolated Tconv (5 × 104) from WT mice cocultured with the indicated number of WT and WKO preactivated nTreg or Tconv cells in the presence of anti-CD3 (2 μg/mL) and irradiated, T-depleted APCs. (B) B cells (5 × 104) from WT mice were stimulated with LPS (3 μg/mL) and cocultured with the indicated number of preactivated nTreg, Tconv, or CD8+ cells from both WT or WKO mice in the presence of soluble anti-CD3 (2 μg/mL) and irradiated T-depleted APCs. (C) B cells isolated from WKO mice were cultured as in panels A and B. Proliferation was then assessed as incorporation of [3H]-thymidine after the cells were pulsed for the last 16 hours during a total of 72 hours of cultures. Note that the proliferation of effector T cells (nTreg, Tconv, and CD8 T cells) cultured alone in the presence of soluble anti-CD3 and LPS stimulation is also shown. Statistical significance of differences between samples was calculated using the 2-tailed Mann-Whitney test with 95% confidence intervals. Results are mean of triplicate cultures and are representative of at least 3 experiments. P < .05.
Figure 2
Figure 2
Defective B-cell death induction and granzyme B release by WKO nTreg cells. (A) Percentage of apoptotic B220+ cells after coculture of activated nTreg and CD8+ cells from WKO or WT mice with LPS-induced B-cell blasts at a ratio of 5:1 in the presence or absence of anti-CD3 antibody and LPS (0.5 μg/mL). Bar graph represents the results of 11 independent experiments expressed as mean ± SD. *P < .0001. **P < .05. NS indicates not significant. (B) Granzyme B (Gzmb) and perforin (Prf1) expression in WKO and WT preactivated nTreg and CD8+ cells. Open histograms represent isotype controls; and solid histograms, Gzmb- and Prf1-specific staining. Representative data from at least 3 independent experiments are shown. (C) ELISA determination of granzyme B (Gzmb) release in culture media by preactivated WT and WKO nTreg and CD8+ cells after restimulation with 2 μg/mL anti-CD3 antibody. Results are mean ± SD of 5 independent experiments. *P = .0260. Statistical significances of differences among samples were calculated using the 2-tailed Mann-Whitney test. (D) Percentage of CD107a+ after culture of WKO and WT-activated nTreg and CD8+ cells (5 × 104) with 2 μg/mL soluble anti-CD3 and irradiated T cell–depleted spleen cells (5 × 104) for 8 hours in the presence of FITC-anti–mouse CD107a or FITC-conjugated isotype control and GolgiStop (BD Biosciences PharMingen). After restimulation, the cells were stained with anti-CD107a, anti-CD4, and anti-CD8 and analyzed by flow cytometry. Results are mean ± SD of 3 independent experiments. *P = .0317. Statistical significances of differences among samples were calculated using the 2-tailed Mann-Whitney test. (E-F) Defective suppression of B-cell proliferation and LPS-induced B-cell blast killing by WKO-OT2 nTreg cells. (E) B cells (5 × 104) from WT mice were stimulated with LPS (3 μg/mL) and cocultured with equal number of preactivated nTreg cells from both WT or WKO mice in the presence of OVA323-339 peptide (10μM), and irradiated T-depleted APCs. Proliferation was then assessed as in Figure 1. (F) B-cell blasts were pulsed with OVA323-339 peptide (10μM) for 2 hours and cultured alone or with WKO or WT OT-2 nTreg cells at an effector-to-target ratio of 1:1 for 8 hours in the presence of LPS (0.5 μg/mL). Statistical significance of differences between samples was calculated using the Mann-Whitney test with 95% confidence intervals. Results are mean of triplicate cultures and are representative of at least 2 experiments.

References

    1. Bosticardo M, Marangoni F, Aiuti A, Villa A, Grazia Roncarolo M. Recent advances in understanding the pathophysiology of Wiskott-Aldrich syndrome. Blood. 2009;113(25):6288–6295. - PubMed
    1. Ochs HD, Thrasher AJ. The Wiskott-Aldrich syndrome. J Allergy Clin Immunol. 2006;117(4):725–738. quiz 739. - PubMed
    1. Zhang J, Shehabeldin A, da Cruz LA, et al. Antigen receptor-induced activation and cytoskeletal rearrangement are impaired in Wiskott-Aldrich syndrome protein-deficient lymphocytes. J Exp Med. 1999;190(9):1329–1342. - PMC - PubMed
    1. Westerberg L, Larsson M, Hardy SJ, Fernandez C, Thrasher AJ, Severinson E. Wiskott-Aldrich syndrome protein deficiency leads to reduced B-cell adhesion, migration, and homing, and a delayed humoral immune response. Blood. 2005;105(3):1144–1152. - PubMed
    1. Humblet-Baron S, Sather B, Anover S, et al. Wiskott-Aldrich syndrome protein is required for regulatory T cell homeostasis. J Clin Invest. 2007;117(2):407–418. - PMC - PubMed

MeSH terms